Predicting atrial fibrillation in primary care using machine learning
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Background: Atrial fibrillation (AF) is the most common sustained heart arrhythmia. Difficulties in diagnosing AF - particularly when paroxysmal and asymptomatic - and lack of routine screening contribute to underdiagnoses. Efficient, cost-effective detection of the undiagnosed may be supported by risk-prediction models relating patient factors to AF risk. However, there exists a need for an implementable risk model that is contemporaneous and informed by routinely collected patient data, reflecting the real-world pathology of AF. Methods: Machine learning and conventional statistical models were evaluated using patients identified from UK healthcare records, aged ≥30 years, without a history of AF, from January-2006 to December-2016. A matched case-control study evaluated published risk models (Framingham, ARIC, CHARGE-AF), machine learning models using baseline and time-updated information (neural network, LASSO, random forests, support vector machines) and Cox regression. Models were ranked with maximal discrimination between AF and non-AF cases (area under the receiver operating characteristic curve, AUROC) and potential number-needed-to-screen (NNS) to detect a case of AF. Findings: Analysis of 2,994,837 patients (3.2% AF) identified time-varying neural networks as the optimal model. Compared to the best existing model CHARGE-AF, the optimal model achieved an AUROC of 0.827 vs. 0.725, with NNS of 9 vs. 13 patients at 75% sensitivity. The optimal model confirmed known baseline risk factors (age, previous cardiovascular disease, antihypertensive medication usage) and identified additional time-varying predictors previously unknown (recency of cardiovascular events, body mass index (both levels and changes), pulse pressure, and the frequency of blood pressure measurements). Interpretation: The optimal time-varying machine learning model exhibited greater predictive performance than existing AF risk models and reflected known and new relationships between patient risk factors for AF. If utilised, the model may help improve the precision of AF screening, leading to better patient outcomes and cost-effective use of healthcare resources. Funding: Bristol-Myers Squibb and Pfizer. Declaration of Interest: NR Hill, U Farooqui, & S Lister are employees of Bristol-Myers Squibb Company. M Lumley is an employee of Pfizer Inc. D Ayoubkhani, P McEwan, D M Sugrue, J Gordon are employed by HEOR ltd., which provides consulting and other research services to pharmaceutical, medical device, and related organizations. In their salaried positions, they work with a variety of companies and organizations, and are precluded from receiving payments or honoraria directly from these organizations for services rendered. AT Cohen reports grants and personal fees from Bristol-Myers Squibb Company and Pfizer Inc. during the conduct of the study; personal fees from Boehringer Ingelheim, grants and personal fees from Bristol-Myers Squibb Company, grants and personal fees from Daiichi-Sankyo Europe, personal fees from Johnson & Johnson, grants and personal fees from Pfizer, Inc., personal fees from Portola, personal fees from Sanofi, personal fees from XO1, personal fees from Janssen, personal fees from ONO Pharmaceuticals, and grants and personal fees from Bayer AG, outside the submitted work. A Bakhai reports personal fees from Bristol-Myers Squibb Company and Pfizer Inc. during the conduct of the study; personal fees from Boehringer Ingelheim, personal fees from Bristol-Myers Squibb Company, personal fees from Daiichi-Sankyo Europe, personal fees from Johnson & Johnson, personal fees from Pfizer, Inc., personal fees from Novartis, personal fees from Sanofi, personal fees from MSD, personal fees from Janssen, personal fees from Roche, and personal fees from Bayer AG, outside the submitted work. DA Clifton reports personal fees from Bristol-Myers Squibb Company during the conduct of the study; and outside the submitted work, personal fees from Drayson Health (now Sensyne Health), personal fees from Ferrovial plc., personal fees from Quanta Dialysis, and personal fees from BioBeats Ltd. M O’Neill reports personal fees from Bristol-Myers Squibb Company and Pfizer Inc. during the conduct of the study; grants and personal fees from Biosense Webster, grants and personal fees from Abbott, personal fees from Siemens, personal fees from Vytronus, personal fees from Medtronic outside the submitted work. Ethical Approval: The study protocol was reviewed and approved by the Independent Scientific Advisory Committee for MHRA database research (ISAC, reference number 17_151).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Cortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Deo, R. C. (2015) · Circulation · doi:10.1161/circulationaha.115.001593 · Cited by 3,466
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667
Can machine-learning improve cardiovascular risk prediction using routine clinical data?
Weng, S. F., Reps, J., Kai, J., Garibaldi, J. M., & Qureshi, N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174944 · Cited by 1,346
Cited by
Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights
Kornej, J., Börschel, C. S., Benjamin, E. J., & Schnabel, R. B. (2020) · Circulation Research · doi:10.1161/circresaha.120.316340 · Cited by 1,516
Application of artificial intelligence to the electrocardiogram
Attia, Z. I., Harmon, D. M., Behr, E. R., & Friedman, P. A. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab649 · Cited by 312
Liu, T., Krentz, A., Lu, L., & Curcin, V. (2025) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztae080 · Cited by 177
Brnabic, A., & Hess, L. M. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01403-2 · Cited by 123
How will machine learning inform the clinical care of atrial fibrillation?
Siontis, K. C., Yao, X., Pirruccello, J. P., Philippakis, A. A., & Noseworthy, P. A. (2020) · Circulation Research · doi:10.1161/circresaha.120.316401 · Cited by 61
Metadata
- Authors
- Hill, N. R., Ayoubkhani, D., McEwan, P., Sugrue, D. M., Farooqui, U., Lister, S., Lumley, M., Bakhai, A., Cohen, A. T., O’Neill, M., Clifton, D., & Gordon, J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-11-01
- Volume
- 14
- Issue
- 11
- Pages
- e0224582
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2987212315
- Cited by
- 137
- References
- 13
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predicting atrial fibrillation in primary care using machine learning. https://app.cochat.ai/papers/10.1371/journal.pone.0224582
- The paper
- Hill, N. R., Ayoubkhani, D., McEwan, P., Sugrue, D. M., Farooqui, U., Lister, S., Lumley, M., Bakhai, A., Cohen, A. T., O’Neill, M., Clifton, D., & Gordon, J. (2019). Predicting atrial fibrillation in primary care using machine learning. PLOS ONE. https://doi.org/10.1371/journal.pone.0224582
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.